<DOC>
	<DOC>NCT01461954</DOC>
	<brief_summary>This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to show superiority of FST-100 ophthalmic suspension compared to vehicle for clinical resolution of acute viral conjunctivitis.</brief_summary>
	<brief_title>FST-100 in the Treatment of Acute Viral Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Viral</mesh_term>
	<criteria>Have a clinical diagnosis of suspected acute viral conjunctivitis in at least one eye Have a known sensitivity to any of the components of FST100 or FST100 vehicle</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>